Feed GWLL
GW
Goldenwell Biotech, Inc. GWLL OTC · Healthcare · United States
$0.60 +0.00% +$0.00
Depth
- Market cap
- $59.4M
- Enterprise value
- $59.7M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 2,560.9x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- 133.6%
- Gross margin
- 107.8%
- Net margin
- -1,130.5%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 5.07
- Free float
- 36.4%
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Shuang Liu
Employees
3
Headquarters
Solon
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What to watch: Revenue fell by 90% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: It earns 134 USD a year on every 100 USD of invested capital.
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What to watch: It passes only 1 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number